Complement Activation and Up-Regulated Expression of Anaphylatoxin C3a/C3aR in Glioblastoma: Deciphering the Links with TGF-β and VEGF
Article in Cancers (May 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Nucleotide‐Binding Oligomerization Domain (NOD)-Like Receptor Subfamily C (NLRC) as a Prognostic Biomarker for Glioblastoma Multiforme Linked to Tumor Microenvironment: A Bioinformatics, Immunohistochemistry, and Machine Learning-Based Study
Article in Journal of Inflammation Research (February 2023)
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment
Article in Current Oncology (December 2022)